(Q43805657)

27 November 2017

Rash from antiepileptic drugs: influence by gender, age, and learning disability (English)

1 reference

27 November 2017

0 references

Silje Alvestad

1

1 reference

PubMed ID

17484761

27 November 2017

Stian Lydersen

series ordinal

2

1 reference

PubMed ID

17484761

27 November 2017

Eylert Brodtkorb

series ordinal

3

1 reference

27 November 2017

1 May 2007

1 reference

27 November 2017

1 reference

27 November 2017

48

1 reference

27 November 2017

7

1 reference

27 November 2017

1360-1365

1 reference

Children versus adults: pharmacokinetic and adverse-effect differences

27 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01109.X

Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01109.X

Sex hormones and glucocorticoids: interactions with the immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01109.X

Adverse effects of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01109.X

Lamotrigine-associated rash: risk/benefit considerations in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01109.X

Predictors of Lamotrigine-associated rash

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01109.X

Oxcarbazepine, an antiepileptic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01109.X

Anticonvulsant hypersensitivity syndrome: incidence, prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01109.X

Safety of long-term lamotrigine in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01109.X

Metabolism of Lamotrigine to a Reactive Arene Oxide Intermediate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01109.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01109.X

Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01109.X

Therapeutic implications of sex differences in asthma and atopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01109.X

Mitochondrial impairment in the cerebellum of the patients with progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01109.X

Immune mechanisms in drug allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01109.X

Oxcarbazepine for Treatment of Partial Epilepsy: A Review and Recommendations for Clinical Use

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01109.X

Drug eruptions and other adverse drug effects in aged skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01109.X

Mechanisms of the hygiene hypothesis--molecular and otherwise

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01109.X

Factors Influencing the Incidence of Lamotrigine-Related Skin Rash

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01109.X

10.1111/J.1528-1167.2007.01109.X

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference

PubMed ID

17484761